BDSI takes on full ownership of BEMA drug delivery tech
BioDelivery Sciences International (BDSI) has acquired the US rights to the BEMA oral adhesive disc drug delivery technology for $3m, with a further $4m to be paid at a later date.
Archives for September 10, 2007
FDA probe ghost stops haunting MDS Pharma
It seems that the ghost of the US Food and Drug Administration (FDA) probe has stopped haunting MDS Pharma as the firm posted encouraging financial results in the third quarter.
Biotest scoops up ailing Nabi's biologics unit
German firm Biotest has bought up Nabi Biopharmaceuticals biologics division in a multi-million Euro deal, less than three months after the unit was created following Nabi restructuring efforts.
Enzo appeals as patent claims against ABI dismissed
Enzo Biochem has lodged an appeal after its patent infringement claims against Applied Biosystems (ABI) were dismissed on Friday in a summary judgement.
BioVascular, Revitus join forces to target vascular disease
Two privately held biotech companies developing compounds to prevent blood clots have merged as their second drug candidate enters clinical trials.
Evotec hives off chemical development biz
German firm Evotec has sold off its chemical and pharmaceutical development (CPD) business along with the associated facilities in the UK.
Second new class of HIV drug given thumbs up
Merck & Co.'s integrase inhibitor, the first in a new class of HIV drug, looks likely to win approval in the near future, following a recommendation to regulators.
AstraZeneca to help Biovator replace in vivo allergy testing
AstraZeneca (AZ) is to assist Biovator in the development of its in vitro test for identifying potential allergens that could replace many experiments on animals.
Averion ventures into Brazil
Averion has formed a new partnership in South America's clinical trial hotspot Brazil - as it continues to tip-toe beyond North America and Europe into emerging markets.
Pfizer blighted by Viracept scare
It appears that pharma heavyweight Pfizer has not emerged unscathed from the contamination chaos that has affected EU supplies of HIV drug Viracept (nelfinavir), with the company this week warning that its version of the treatment is also tainted with...
Crospon to make drug delivery smarter
Irish start-up Crospon has licensed a 'smart' drug delivery skin patch technology from HP Labs that uses inkjet printing technology to deliver drugs under the skin.